Adial Pharmaceuticals, Inc. (ADIL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

In simple words, this is a beast machine, and driving it is awesome. The built quality is really good. I have been riding this scooter for the last five months and have had no issues until now.